Related Experiment Videos
Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues
1Department of Pediatrics, University of Colorado School of Medicine, Denver.
Insights
Bronchopulmonary dysplasia (BPD) remains a major complication of prematurity despite advances. Research focuses on prevention and healing, but long-term respiratory and neurodevelopmental issues persist, posing ongoing challenges.
Area of Science:
- Neonatal Medicine
- Pulmonology
- Perinatal Research
Background:
- Bronchopulmonary dysplasia (BPD) is a significant complication of prematurity, persisting despite 25 years of research.
- Advances in understanding BPD pathophysiology and pathogenesis have led to new therapeutic interventions.
- Long-term respiratory and neurodevelopmental complications affect survivors into adulthood.
Purpose of the Study:
- To review current research on the prevention and treatment of Bronchopulmonary dysplasia (BPD).
- To explore novel therapeutic strategies for accelerating lung maturation and minimizing lung injury in premature infants.
- To discuss the ongoing challenges in managing chronic lung disease and its associated complications in survivors.
Main Methods:
- Review of current research on BPD prevention and treatment strategies.
- Exploration of novel approaches including maternal steroid and thyrotropin releasing hormone (TRH) therapy, surfactant replacement, and advanced ventilation techniques.
- Discussion of ongoing studies on inflammatory products, growth factors, and cytokines for lung healing.
Main Results:
- Current research emphasizes prevention through strategies like maternal steroid and TRH therapy, surfactant replacement, and advanced ventilation.
- Technologies such as synchronized intermittent mandatory ventilation and inhaled nitric oxide may be used for severe neonatal respiratory failure.
- Studies on inflammatory products, growth factors, and cytokines are exploring therapies to aid lung healing.
Conclusions:
- Despite improved survival rates for premature infants, managing BPD and its long-term consequences remains a significant challenge.
- Future research needs to address the unknown potential for normal pulmonary growth and development in survivors.
- Continued investigation into inflammatory pathways and growth factors is crucial for developing therapies to improve lung healing and long-term outcomes.
Abstract:
Although much has been learned about BPD in the 25 years since its initial description, BPD remains a significant complication of prematurity. Substantial advances into the understanding of its pathophysiology and pathogenesis have been made and are reflected in new therapeutic interventions. Much current research is directed towards the role of prevention, exploring new approaches for accelerating lung maturation with combined maternal steroid and thyrotropin releasing hormone (TRH) therapy, surfactant replacement therapy, high frequency oscillatory ventilation, antioxidant administration, manipulation of endogenous antioxidants, and other pharmacologic strategies to minimize lung injury. The impact of other technologies, such as synchronized intermittent mandatory ventilation, perfluorocarbon (liquid) ventilation, and perhaps inhaled nitric oxide therapy may become additional parts of the clinical regimen for some cases of severe neonatal respiratory failure. Less information is available on mechanisms which can hasten lung healing. Ongoing studies of inflammatory products, growth factors, and cytokines may lead to new therapies which will favorably influence the fibroproliferative phase of disease. In the meantime, the medical and social impact of BPD continues to remain a significant problem not only during infancy but also throughout life. Mildred Stahlman, MD, recently wrote that (a)s sanguine as the future looks for surfactant therapy, it may leave us with more very low-birth weight infants who survive, whose potential for normal pulmonary growth and development is unknown, and whose very immature organ systems, besides the lung, are still susceptible to metabolic, neurologic, and other problems. As more survivors are reaching young adulthood, respiratory and neurodevelopmental complications persist. Thus, as advances in the care of the premature newborn with respiratory distress have dramatically improved survival, the management of chronic lung disease and related problems remains a continuing challenge.